Regulation of vascular smooth muscle cell apoptosis: Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway

Circulation Research

Volumn 85, Issue 3, 1999, Pages 229-237

  Bai, Hong Zhi ^a   Pollman, Matthew J ^a   Inishi, Yoji ^a   Gibbons, Gary H ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Bad; Insulin like growth factor I; Phosphatidylinositol 3 kinase; Programmed cell death; Vascular smooth muscle cell

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PHOSPHATIDYLINOSITOL 3 KINASE; SOMATOMEDIN C; WORTMANNIN;

APOPTOSIS; ARTICLE; CELL FATE; CELL SURVIVAL; CELL VIABILITY; DOSE RESPONSE; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PHARMACOLOGICAL BLOCKING; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATOR GENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 0033529702     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.3.229     Document Type: Article

References (34)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;62:801-809.
2. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med. 1994;330:1431-1438.
3. Gibbons GH, Dzau VJ. Molecular therapies for vascular diseases. Science. 1996;272:689-693.
4. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
5. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
6. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1-β-converting enzyme. Am J Pathol. 1995;147:251-266.
7. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;7:2883-2890.
8. Bennett MR, Evans GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
9. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995;267: 2003-2006.
10. Reed JC. Double identity for proteins of the Bcl-2 family. Nature. 1997; 387:773-776.
11. Pollman MJ, Sherwood SW, Gibbons GH. Cell cycle arrest induces vascular smooth muscle cell programmed cell death: implications for antiproliferative therapies for restenosis. Circulation. 1995;92 (suppl I):I-101. Abstract.
12. Kimura K, Hattori S, Kabuyama Y, Shizawa Y, Takayanagi J, Nakamura S, Toki S, Matsuda Y, Onodera K, Fukui Y. Neuric outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem. 1994;269:18961-18967.
13. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994;269:5241-5248.
14. Pollman MJ, Yamada T, Horiuchi M, Gibbons GH. Vasoactive substances regulate vascular smooth muscle cell apoptosis: countervailing influences of nitric oxide and angiotensin II. Circ Res. 1996;79: 748-756.
15. Hu Z, Shi X, Lin RZ, Hoffman BB. α1 adrenergic receptors activate phosphatidyl inositol 3-kinase in human vascular smooth muscle cells. J Biol Chem. 1996;271:8977-8982.
16. Hara K, Yonezawa K, Sakue H, Ando A, Kotani K, Kitamura T, Kitamura Y, Ueda H, Stephens L, Jackson TR, Hawkins PT, Dhand R, Clark AE, Holman GD, Waterfield MD, Kasuga M. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci USA. 1994;91:7415-7419.
17. Parrizas M, Saltiel AR, LeRoith D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J Biol Chem. 1997;272:154-161.
18. Peso LD, Gonzalez-Garcia M, Page C, Herrera R, Nunez G. Interleukin-3-induced phosphorylation of Bad through the protein kinase Akt. Science. 1997;278:687-689.
19. Dudek H, Dotta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 1997;275:661-665.
20. Zha J, Harada H, Osipov K, Jockel J, Waksman G, Korsmeyer SJ. BH3 domain of BAD is required for heterodimerization with Bcl-XL and pro-apoptotic activity. J Biol Chem. 1997;272:24101-24104.
21. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding 14-3-3 not Bel-XL. Cell. 1996;87:619-628.
22. Stokoe D, Stephens LR, Copeland T, Gaffney PRJ, Reese CB, Painter GF, Holmes AB, McCormick F, Hawkins PT. Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B. Science. 1997;277:567-570.
23. Marianna P, Cooper GM. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem. 1998;273:19929-19932.
24. Minshall C, Arkins S, Freund CG, Kelley KW. Requirement for phosphatidylinositol 3-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J Immunol. 1996; 156:936-947.
25. Toker A, Cantley LC. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997;387:673-676.
26. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G. Suppression of c-Myc-induced apoptosis by Ras signaling through PI(3)K and PKB. Nature. 1997;385:544-548.
27. Franke TF, Yang S, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. The protein kinase encoded by the protooncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995;81:727-736.
28. Coffer PJ, Jin J, Woodgett JR. Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J. 1998; 335:1-13.
29. Evan G, Littlewood T. A matter of life and cell death. Science. 1998; 281:1317-1322.
30. Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH. Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease. Nat Med. 1998;4:222-227.
31. Chinnaiyan AM, O'Rourke K, Lane BR, Dixit YM. Interaction of ced-3 and ced-9: a molecular framework for cell death. Science. 1997;275:1122-1126.
32. Decaudin D, Geley S, Hirsch T, Castedo M, Marchetti P, Macho A, Kofler R, Kroemer G. Bcl-2 and Bel-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 1997;57:62-67.
33. Kharbanda S, Pandey P, Schofield L, Israels S, Roncinske R, Yoshida K, Bharti A, Yuan Z, Saxena S, Weichselbaum R, Nalin C, Kufe D. Role of Bcl-XL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. Proc Natl Acad Sci U S A. 1997;94: 6939-6942.
34. Datta SR, Dudek H, Tao X, Masters S, Fu HS, Gotoh Y, Greenberg ME. Akt phosphorylation of Bad couples survival signals to the cell intrinsic death machinery. Cell. 1997;91:231-241.